TP53 and hepatocellular carcinoma: Consistently, it has been shown that the expression of miR-34a is shortened in hepatoma cells as well as in tumor samples, since it exerts its anti-malignancy activities via p53/miR-34a/SIRT1 positive feedback loop [85,86].